Yumanity Therapeutics, Inc.

  Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. The company is initially focused on discovering disease-modifying therapies for patients with Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).   
Team: 
Dennis Ray
Leslie Gunatilaka
Kithsiri Wiljeratne
Yaming Xu